Contact this trialFirst, we need to learn more about you.
Monoclonal Antibodies
Frexalimab for Multiple Sclerosis
Recruiting1 awardPhase 3
Oklahoma City, Oklahoma
This trial is studying a drug called frexalimab to see if it can help delay disability progression in people with a certain type of multiple sclerosis. The study will last between 27 to
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.